Sayona John, MD

Biography

Sayona John, MD, completed her residency training from the University of Mississippi in 2005 and fellowships in neurocritical care and stroke from the Massachusetts General Hospital in Boston in 2007. She joined Rush University in 2008 after working for one year at the University of Texas Southwestern in Dallas. She became the medical director of the neuroscience intensive care unit in 2011 and the section head of critical care neurology in 2012. Her research interests primarily involve patients with intracerebral hemorrhage. She was nominated as an executive committee member for the NIH-sponsored CLEAR III trial and was the top enroller for this trial.

Honors and Activities

Fellow of the Neurocritical Care Society

Publications

http://www.ncbi.nlm.nih.gov/pubmed/?term=John%20S%5BAuthor%5D&cauthor=true&cauthor_uid=26572141

Grants

Reversal of Dabigatran Anticoagulant Effect With Idarucizumab (RE-VERSE-AD)
Role: Site Principal Investigator
Granted 2/2016
Fund number: 34865
Prospective Study on Intravenous Thrombolysis Related Coagulopathy in Acute Ischemic Stroke

Role: Co-Principal Investigator
Granted 5/2015
Grant Amount: $20,000
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III (CLEAR III)
Role: Permanent Executive Committee Member and Site Principal Investigator
Clear III is a five-year double blinded, placebo controlled, Phase III trial testing the benefit of clot removal for intraventricular hemorrhage.
NIH fund number: NCT00784134

PRINCE Study: Point Prevalence study In Neurocritical Care
Role: Site Principal Investigator
Unfunded study supported by the Neurocritical Care Society and the Neurocritical Care Research Network

Education

Research Areas